Find the best solutions to your questions at Westonci.ca, the premier Q&A platform with a community of knowledgeable experts. Connect with a community of experts ready to help you find accurate solutions to your questions quickly and efficiently. Explore comprehensive solutions to your questions from a wide range of professionals on our user-friendly platform.
Sagot :
Vasodilation, enhanced vascular permeability, and increased renal excretion of salt and water are at least three of the acute mechanisms through which atrial natriuretic peptide (ANP) reduces plasma volume.
The NPPA gene in humans encodes the natriuretic peptide hormone known as atrial natriuretic peptide (ANP) or atrial natriuretic factor (ANF), which is secreted by the cardiac atria.
In order to discriminate between the effects of ANP-dependent increases in vascular permeability and those of other endocrine actions of ANP in the regulation of plasma volume, authors of a study in this issue of the JCI carried out a knockout of the ANP receptor in vascular endothelia. Reduced vascular permeability to plasma protein was seen in the knockout animals, which led to chronically elevated plasma volume, arterial hypertension, and cardiac hypertrophy.
These modifications were not explained by vasodilation or renal excretion. Thus, ANP's capacity to reduce arterial blood pressure may depend on the extent to which it enhances endothelial permeability.
Learn more about atrial natriuretic peptide (ANP) is visit here;
https://brainly.com/question/28266783
#SPJ4
We appreciate your time on our site. Don't hesitate to return whenever you have more questions or need further clarification. Thanks for using our platform. We aim to provide accurate and up-to-date answers to all your queries. Come back soon. Your questions are important to us at Westonci.ca. Visit again for expert answers and reliable information.
